Clinical Trial Update: Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence [Phase 2]

View source ↗

Summary

A Phase 2 open-label trial of Depakote ER in patients with bipolar I/II depression and alcohol use disorder has been withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Bipolar Disorder
• Bipolar Ii Disorder

Drugs mentioned

• DEPAKOTE ER (DIVALPROEX SODIUM)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Bipolar I or II Depression and Alcohol Abuse or Dependence | Phase 2 | Status: WITHDRAWN